Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vanda Pharmaceuticals buy B. Riley Financial, Inc.

Vanda Pharmaceuticals
Start price
€4.34
10.08.26 / 50%
Target price
€10.39
10.08.27
Performance (%)
-2.31%
Price
€4.30
07.08.26
Summary
This prediction is currently active. With a performance of -2.31%, the BUY prediction by B__Riley_Financial__ is trending in the wrong direction. This prediction currently runs until 10.08.27. The prediction end date can be changed by B__Riley_Financial__ at any time. B__Riley_Financial__ has 50% into this prediction
Performance without dividends (%)
Name 1w
Vanda Pharmaceuticals -2.31%
iShares Core DAX® 1.001%
iShares Nasdaq 100 2.702%
iShares Nikkei 225® 3.519%
iShares S&P 500 1.766%

Comments by B__Riley_Financial__ for this prediction

In the thread Vanda Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -2.31%
Target price 10.386
Change
Ends at 10.08.27

Vanda Pharmaceuticals (VNDA) had its "buy" rating reaffirmed by B. Riley Financial, Inc.. They now have a $12.00 price target on the stock, down from $17.00.
Ratings data for VNDA provided by MarketBeat

B. Riley Financial, Inc. 
0
Report Share
10.08.26